Ignite Creation Date:
2024-05-06 @ 6:42 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05756777
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-02-08
Brief Title:
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia AML
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-26
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-02
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-08
First Submit QC Date:
March 3 2023
Study First Post Date:
2023-03-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-09
Last Update Post Date:
2024-07-03
Last Update Post Date Type:
ACTUAL